Yvonne Bouter Selected Research

Yvonne Bouter Research Topics

19	Alzheimer Disease (Alzheimer's Disease) 03/2024 - 08/2013
4	Memory Disorders (Memory Loss) 01/2023 - 12/2015
3	Amyloid Plaque 01/2022 - 09/2013
2	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2022 - 01/2016
2	Cognitive Dysfunction 01/2019 - 01/2018
1	Inflammation (Inflammations) 03/2022
1	Down Syndrome (Down's Syndrome) 01/2022
1	Persistent Infection 09/2018
1	Infections 09/2018
1	Osteomyelitis 09/2018
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 11/2015
1	Amyloid angiopathy 04/2014

10	Amyloid (Amyloid Fibrils)IBA 01/2022 - 09/2013
6	Peptides (Polypeptides)IBA 01/2018 - 08/2013
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2019
3	Pyrrolidonecarboxylic Acid (Pyroglutamic Acid)IBA 01/2018 - 01/2015
3	Presenilin-1IBA 01/2016 - 09/2013
2	crenezumabIBA 03/2024 - 11/2015
2	solanezumabIBA 03/2024 - 11/2015
2	Biosimilar PharmaceuticalsIBA 03/2024 - 11/2015
2	bapineuzumabIBA 03/2024 - 11/2015
2	AntibodiesIBA 03/2024 - 11/2015
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2016
1	CB2 Cannabinoid ReceptorIBA 01/2023
1	(3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA 01/2023
1	CannabinoidsIBA 03/2022
1	donanemabIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Amyloid beta-PeptidesIBA 01/2022
1	VaccinesIBA 01/2022
1	4- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA 01/2020
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2020
1	Untranslated RNA (Noncoding RNA)IBA 01/2020
1	Chemokine ReceptorsIBA 09/2018
1	68Ga-pentixaforIBA 09/2018
1	Presenilin-2IBA 01/2016
1	Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA 01/2016
1	Immunoglobulin Fab FragmentsIBA 12/2015
1	Humanized Monoclonal AntibodiesIBA 11/2015
1	Amino Acids FDA Link 01/2015
1	Flavin-Adenine Dinucleotide (FAD)IBA 04/2014

2	Therapeutics 01/2019 - 01/2018